Article

ZNF143 activates gene expression in response to DNA damage and binds to cisplatin-modified DNA.

Department of Molecular Biology, University of Occupational and Environmental Health, School of Medicine, Fukuoka, Japan.
International Journal of Cancer (impact factor: 5.44). 11/2004; 111(6):900-9. DOI:10.1002/ijc.20358 pp.900-9
Source: PubMed

ABSTRACT We have identified a cisplatin-inducible gene, the mitochondrial ribosomal protein S11 (MRP S11) gene, by means of mRNA differential display. Functional analysis of the MRP S11 promoter showed that a Staf binding site in the promoter is required for both basal promoter activity and cisplatin-inducible activity. We also found that Staf binding activity is significantly increased in nuclear extracts from cells treated with cisplatin. ZNF 143 and ZNF 76 are human homologues of the Xenopus transcriptional activator, Staf. ZNF 143 expression is induced by cisplatin but ZNF 76 expression is not. However, ZNF 143 expression is not induced by transplatin, which is clinically ineffective. ZNF143 is an inducible gene by other DNA damaging agents such as gamma-irradiation, etoposide and adriamycin. ZNF 143 also binds preferentially to cisplatin-modified DNA. These results suggest that ZNF 143 participates in cellular responses to DNA damage.

0 0
 · 
0 Bookmarks
 · 
28 Views

Keywords

cisplatin-modified DNA
 
clinically ineffective
 
DNA damage
 
DNA damaging agents
 
etoposide
 
Functional analysis
 
mitochondrial ribosomal protein S11
 
mRNA differential display
 
MRP S11 promoter
 
nuclear
 
Staf
 
Staf binding activity
 
Staf binding site
 
Xenopus transcriptional activator
 
ZNF 143 expression
 
ZNF 143 participates